Hottub News

AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials

1 report from 1 outlet in 1 language · first reported · updated · JSON

HealthAbbVie

Reports

  1. AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trialsmedicaldaily.com · en ·

More in Health

  1. Democratic Republic of Congo: More than 4,000 people in the DR Congo have died from Ebola98 outlets
  2. Former Eljamel patient’s ‘shock’ at health board’s approach to inquiry131 outlets
  3. More than 4000 Ebola deaths in Democratic Republic of Congo63 outlets
  4. Life expectancy almost back to pre-Covid levels, says WHO41 outlets
  5. Disease-carrying ticks 'living for longer' in UK37 outlets
  6. Here's why experts say now is an ideal time to protect yourself from flu45 outlets